| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 145.590 | 152.978 | 147.412 | 137.385 | 81.358 | 236.472 | 244.150 | 123.244 | 87.763 | 19.890 |
| Total Income - EUR | 156.355 | 128.116 | 161.027 | 134.006 | 160.101 | 144.198 | 217.743 | 145.476 | 89.648 | 22.334 |
| Total Expenses - EUR | 141.651 | 112.912 | 154.451 | 123.543 | 163.414 | 102.825 | 167.259 | 125.731 | 90.970 | 40.698 |
| Gross Profit/Loss - EUR | 14.704 | 15.204 | 6.577 | 10.463 | -3.313 | 41.373 | 50.484 | 19.745 | -1.321 | -18.363 |
| Net Profit/Loss - EUR | 14.704 | 12.981 | 5.086 | 9.088 | -4.089 | 39.350 | 48.765 | 18.617 | -1.649 | -18.363 |
| Employees | 8 | 10 | 7 | 7 | 7 | 7 | 7 | 5 | 3 | 0 |
Check the financial reports for the company - Biotherm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 22.713 | 50.221 | 52.683 | 48.189 | 38.886 | 43.445 | 56.799 | 84.324 | 67.160 | 47.091 |
| Current Assets | 57.791 | 33.071 | 40.819 | 71.174 | 118.965 | 101.055 | 99.025 | 47.475 | 44.832 | 18.234 |
| Inventories | 31.390 | 1.844 | 10.728 | 5.155 | 83.807 | 27.482 | 135 | 136 | 721 | 717 |
| Receivables | 21.821 | 29.239 | 27.058 | 49.771 | 29.311 | 35.948 | 30.659 | 46.513 | 26.633 | 4.804 |
| Cash | 4.580 | 1.987 | 3.032 | 16.248 | 5.847 | 37.624 | 68.230 | 826 | 17.478 | 12.714 |
| Shareholders Funds | -14.796 | -1.663 | 3.451 | 10.210 | 5.969 | 45.205 | 100.079 | 85.288 | 67.982 | 48.801 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 93.695 | 90.607 | 88.385 | 101.628 | 96.939 | 82.203 | 45.620 | 46.889 | 45.360 | 18.364 |
| Income in Advance | 7.214 | 8.404 | 8.397 | 8.271 | 55.525 | 11.040 | 10.799 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2511 - 2511" | |||||||||
| CAEN Financial Year |
2511
|
|||||||||
Comments - Biotherm S.r.l.